USA: A new large-scale cohort study has found that patients newly diagnosed with alopecia areata (AA) face a significantly ...
EBGLYSS (lebrikizumab-lbkz) delivered durable skin clearance and relief from persistent itch for up to four years for ...
In the ADlong Phase 3b study, nearly all EBGLYSS-treated patients achieved meaningful skin improvement (EASI-75) for up to four years 75% of patients achieved a high ...
US President Donald Trump has pushed back his deadline for strikes on Iran's energy assets, saying talks on ending the war ...
© 2026 Forbes Media LLC. All Rights Reserved.
Detailed price information for Avalo Therapeutics Inc (AVTX-Q) from The Globe and Mail including charting and trades.
Data highlights efficacy and safety of risankizumab in psoriatic disease, including high impact areas in psoriasis and long-term treatment of psoriatic ...
Citizens Design Bureau has completed a series of galleries at the V&A to house The Gilbert Collection of decorative arts ...
Seasonal Allergic Rhinitis (SAR) and Perennial Allergic Rhinitis (PAR) - An Endemic Aero-Allergic Disease in India Allergic ...
Objectives To estimate the prevalence of sickle cell trait, sickle cell disease, beta-thalassaemia minor and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results